Cytomegalovirus (CMV) is one of the most common viral pathogens causing clinical disease
in liver transplant recipients, and contributing to substantial morbidity and occasional …

Cytomegalovirus (CMV) is the most common viral pathogen that negatively impacts on the
outcome of liver transplantation. CMV cause febrile illness often accompanied by bone …

Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …

Cytomegalovirus (CMV) infection is the most common viral infection in liver transplant
recipients, affecting post-transplant patients and graft survival. Recent advances in …

Clinical practice guidelines recommend antiviral prophylaxis to cytomegalovirus (CMV)
donor‐positive/recipient‐negative (D+/R−) liver transplant recipients. We assessed the …

Human cytomegalovirus (CMV) represents the most common opportunistic infection in liver
transplant recipients. CMV infections in post liver transplant patients cause significant …

Importance Despite the use of a cytomegalovirus (CMV) prevention strategy of antiviral
prophylaxis for high-risk CMV-seronegative liver transplant recipients with seropositive …

Cytomegalovirus (CMV) infection is an opportunistic infection frequently found after solid
organ transplantation, and it contributes significantly to mortality and morbidity. CMV …

SUMMARY CMV is one of the most frequent viral infections after orthotopic liver
transplantation. Thus, there should be a high index of clinical suspicion, particularly in liver …

This retrospective review compared oral valganciclovir (VGCV) 450 mg daily for 6 months
versus oral ganciclovir (GCV) 1000 mg 3 times daily for 3 months in preventing …